Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
48
pubmed:dateCreated
2009-11-25
pubmed:abstractText
Increased oxidative damage is a prominent and early feature in Alzheimer disease. We previously crossed Alzheimer disease transgenic (APPsw) model mice with alpha-tocopherol transfer protein knock-out (Ttpa(-/-)) mice in which lipid peroxidation in the brain was significantly increased. The resulting double-mutant (Ttpa(-/-)APPsw) mice showed increased amyloid beta (Abeta) deposits in the brain, which was ameliorated with alpha-tocopherol supplementation. To investigate the mechanism of the increased Abeta accumulation, we here studied generation, degradation, aggregation, and efflux of Abeta in the mice. The clearance of intracerebral-microinjected (125)I-Abeta(1-40) from brain was decreased in Ttpa(-/-) mice to be compared with wild-type mice, whereas the generation of Abeta was not increased in Ttpa(-/-)APPsw mice. The activity of an Abeta-degrading enzyme, neprilysin, did not decrease, but the expression level of insulin-degrading enzyme was markedly decreased in Ttpa(-/-) mouse brain. In contrast, Abeta aggregation was accelerated in Ttpa(-/-) mouse brains compared with wild-type brains, and well known molecules involved in Abeta transport from brain to blood, low density lipoprotein receptor-related protein-1 (LRP-1) and p-glycoprotein, were up-regulated in the small vascular fraction of Ttpa(-/-) mouse brains. Moreover, the disappearance of intravenously administered (125)I-Abeta(1-40) was decreased in Ttpa(-/-) mice with reduced translocation of LRP-1 in the hepatocytes. These results suggest that lipid peroxidation due to depletion of alpha-tocopherol impairs Abeta clearances from the brain and from the blood, possibly causing increased Abeta accumulation in Ttpa(-/-)APPsw mouse brain and plasma.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1083-351X
pubmed:author
pubmed:issnType
Electronic
pubmed:day
27
pubmed:volume
284
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
33400-8
pubmed:dateRevised
2011-3-3
pubmed:meshHeading
pubmed-meshheading:19679659-Alzheimer Disease, pubmed-meshheading:19679659-Amyloid Precursor Protein Secretases, pubmed-meshheading:19679659-Amyloid beta-Peptides, pubmed-meshheading:19679659-Animals, pubmed-meshheading:19679659-Blood-Brain Barrier, pubmed-meshheading:19679659-Blotting, Northern, pubmed-meshheading:19679659-Blotting, Western, pubmed-meshheading:19679659-Brain, pubmed-meshheading:19679659-Carrier Proteins, pubmed-meshheading:19679659-Dietary Supplements, pubmed-meshheading:19679659-Disease Models, Animal, pubmed-meshheading:19679659-Female, pubmed-meshheading:19679659-Humans, pubmed-meshheading:19679659-Male, pubmed-meshheading:19679659-Mice, pubmed-meshheading:19679659-Mice, Inbred C57BL, pubmed-meshheading:19679659-Mice, Knockout, pubmed-meshheading:19679659-Mice, Transgenic, pubmed-meshheading:19679659-Tocopherols, pubmed-meshheading:19679659-alpha-Tocopherol
pubmed:year
2009
pubmed:articleTitle
Depletion of vitamin E increases amyloid beta accumulation by decreasing its clearances from brain and blood in a mouse model of Alzheimer disease.
pubmed:affiliation
Department of Neurology and Neurological Science, Graduate School, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519. Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't